Vote for BJP in urban local bodies" poll for "triple engine" govt in UP: Adityanath
UP: Man booked for attempting to rape 5-year-old girl
Congress to mark 100 days of Bharat Jodo Yatra with concert in Jaipur
BJYM, Hindu outfits put off planned protest march at AMU
Karachi battles gas crisis; residents face unannounced load shedding, 2-hr gas supply in a day
Elderly man in judicial custody dies during treatment in UP hospital
Himachal Pradesh skittle Haryana for 46, take 200-run lead on Day 1
Pak court grants protective bail to PM Shehbaz"s son Suleman in money laundering case
British Library celebrates India ties with exhibition on Hampi
Nine policemen suspended after suspect dies in police custody in UP
Gangster"s property attached in UP"s Pratapgarh district
Maoists torch construction company vehicles in Jharkhand’s Chatra district
Sino-India border situation "generally stable": China on Yangtse clash
Babar Azam not taking advice from seniors, claims Shahid Afridi
Qlite Global launches their exclusive Grand Experience Centre
"Disillusioned with central leadership": Sikkim BJP president says he has resigned
2001 attack anniversary: Ready to guard new Parliament if directed, say CRPF heroes
Class 2 student dies after scuffle with fellow students in UP
Three killed in accident in UP"s Lakhimpur KheriLakhimpur Kheri (UP), Dec 13 (PTI) Three motorcycle borne youths were killed and "
Abandoned girl child from Assam adopted by Spanish professor
According to the report, a Mumbai-based pharmaceutical major has received permission from the Drug Controller General of India (DCGI) to conduct human testing of the drug.
Lucknow-based Central Drug research institute (CISR-CDRI) claim to have claim to have developed a medicine to treat dengue.
According to the report, a Mumbai-based pharmaceutical major has received permission from the Drug Controller General of India (DCGI) to conduct human testing of the drug.
Trials will be conducted in 20 cities across the country.
Derived from plants, the medicine, called AQCH, is anti-viral in nature. It was tested successfully in labs and on mice.
Trials will be conducted at one medical college in each of the following cities: Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belgaum, Chennai, Jaipur, Chandigarh, Visakahapatnam, Cuttack, Khurda and Nathdwara.
Kanpur`s Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College, Lucknow`s King George`s Medical University (KGMU) and Agra-based Sarojini Naidu (SN) Medical College will host the exercise in Uttar Pradesh. At each centre, a total of 100 patients will receive this treatment.
A dengue patient should be at least 18 years of age to be eligible for trials. Additionally, infection in the patient should have been confirmed 48 hours before the testing.
The patient will be kept in hospital for eight days, during which he will be administered the drug for seven days. He will be kept under observation for 17 days after being given the medicine.
It is pertinent to note that there is no specific medicine for the treatment of dengue. Patients are treated on the basis of symptoms.
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
